Sony Biotechnology Inc. Sony Biotechnology Inc.cart
About Us Products What's New Library News Calendar Contact Us Place Order
Safety Data Sheet (SDS) PE/Cy7 Anti-human/mouse CD49f Antibody     Product Data Sheet (PDF)    
PE/Cy7 Anti-human/mouse CD49f Antibody
2168105 25 tests $130.00       
2168110 100 tests $300.00       
Clone: GoH3
Isotype: Rat IgG2a, κ
Reactivity: Human, Mouse, Cross-Reactivity: Baboon, Chimpanzee, Capuchin Monkey, Cynomolgus, Rhesus, Horse (Equine), Cattle (Bovine, Cow), Sheep (Ovine), Swine (Pig, Porcine), Dog (Canine), Cat (Feline), Rabbit (Lapine)
Immunogen: Mouse mammary tumor cells
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA (origin USA).
Preparation: The antibody was purified by affinity chromatography and conjugated with PE/Cy7 under optimal conditions. The solution is free of unconjugated PE/Cy7 and unconjugated antibody.
Concentration: Lot-specific (please contact technical support for concentration and total µg amount, or use our Lookup tool if you have a lot number.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application:

FC - Quality tested

Application Notes:

Additional reported applications (for the relevant formats) include: immunoprecipitation1,5, in vitro and in vivo blocking of cell binding to laminin and blocking the function of integrin α61,4, and immunohistochemistry of acetone-fixed frozen sections2,3,5. The GoH3 antibody has been reported to block laminin binding in vitro and to block integrin α6 function in vivo.

Recommended Usage:

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Application References:

1. Georas SN, et al. 1993. Blood 82:2872. (IP, Block)
2. Honda T, et al. 1995. J. Clin. Endocrinol. Metab. 80:2899. (IHC)
3. Sonnenberg A, et al. 1986. J. Histochem. Cytochem. 34:1037. (IHC)
4. Nakamura K, et al. 1997 Biochem. Biophys. Res. Commun. 235:524. (Block)
5. Sonnenberg A, et al. 1987 J. Biol. Chem. 262:10376. (IP, IHC)
6. Deregibus MC, et al. 2007. Blood doi:10.1182/blood-2007-03-078709.
7. Horwitz KB, et al. 2008. Proc Natl Acad Sci USA. 105:5774. PubMed
8. Nardella C, et al. 2009. Sci Signal. 2:55. PubMed
9. Xu T, et al. 2010. Mol Cancer Ther. 9:438. PubMed
10. Stepp MA, et al. 2007. J Cell Sci. 120:2851. PubMed
11. Jo M, et al. 2010. Cancer Res. 70:8948. PubMed
12. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
13. Grange C, et al. 2011. Cancer Res. 71:5346. PubMed
14. Lai KP, et al. 2012. Mol Endocrinol. 26:52. PubMed
15. Oeztuerk-Winder F, et al. 2012. EMBO J. 31:3431. (FC) PubMed

Human peripheral blood lymphocytes were

Human peripheral blood lymphocytes were stained with anti-human/mouse CD49f (clone GoH3) PE/Cy7 (filled histogram) or rat IgG2a, κ PE/Cy7 isotype control (open histogram).



Description:

CD49f is a 120 kD integrin family member also known as VLA-6 α chain and α6 integrin subunit. CD49f associates with either integrin β1 (CD29) or integrin β4 (CD104) to form receptors (VLA-6 or α6β4 complex) for laminin and kalinin. CD49f is expressed on platelets, monocytes, T cells, placental trophoblasts, and epithelial and endothelial cells. CD49f is involved in adhesion and can act as a co-stimulatory molecule for T cell activation and proliferation.

Other Names: VLA-6 α chain, α6 integrin, integrin α6, ITGA6
Structure: Integrin family, associates with β1 or β4, 120 kD
Distribution: Platelets, monocytes, T cells, placental trophoblasts, epithelial and endothelial cells
Function: Adhesion, receptor for laminin and kalinin; laminin binding to VLA-6 induces T cell co-stimulation for proliferation and activation
Ligand Receptor: With integrin β1 (CD29) forms VLA-6, with integrin β4 (CD104) forms a6β4 integrin; laminin and kalinin are ligands for these receptors
Antigen References:

1. Sonnenberg A, et al. 1990. J. Cell Biol. 110:2145.
2. Sonnenberg A, et al. 1990. J. Cell. Sci. 96:207.
3. Aumailley M, et al. 1990. Exp. Cell Res. 188:55.
4. Niessen CM, et al. 1994. Exp. Cell Res. 211:360.


This product or portions thereof is manufactured under license from GE Healthcare under U.S. Patent Numbers 5,268,486; 5,569,587; 5,627,027 and patents or pending applications that are continuations, continuations-in-part, re-examinations, divisionals, reissues or foreign equivalents thereof. THIS MATERIAL IS SUBJECT TO PROPRIETARY RIGHTS OF GE HEALTHCARE BIO-SCIENCES CORP. AND CARNEGIE MELLON UNIVERSITY AND MADE AND SOLD UNDER LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. THIS PRODUCT IS LICENSED FOR SALE ONLY FOR RESEARCH. IT IS NOT LICENSED FOR ANY OTHER USE. THERE IS NO IMPLIED LICENSE HEREUNDER FOR ANY COMMERCIAL USE.
COMMERCIAL USE shall include:

  • sale, lease, license or other transfer of the material or any material derived or produced from it;
  • sale, lease, license or other grant of rights to use this Material or any material derived or produced from it;
  • use of this material to perform services for a fee for third parties.

IF YOU REQUIRE A COMMERCIAL LICENSE TO USE THIS MATERIAL AND DO NOT HAVE ONE RETURN THIS MATERIAL, UNOPENED TO Sony Biotechnology Inc., 2100 South Oak Street, Champaign, IL 61820, USA AND ANY MONEY PAID FOR THE MATERIAL WILL BE REFUNDED.